Novartis (Indonesian Wikipedia)

"The Pharmaceutical Industry in Figures - 2008 Edition". European Federation of Pharmaceutical Industries and Associations (EFPIA). hlm. 49. Diarsipkan dari versi asli (PDF) tanggal 16 September 2008. Diakses tanggal 25 August 2008.

beuc.eu

"Avastin vs Lucentis" (PDF).

biospace.com

"Alcon to Officially Spin out From Novartis on April 9". BioSpace (dalam bahasa Inggris). Diakses tanggal 2020-01-09.
"Novartis AG to Hold On to Its 33% Stake in Roche—For Now". BioSpace (dalam bahasa Inggris). Diakses tanggal 2020-01-10.
"Out From Under Novartis, Alcon Is Its Own Company Now". BioSpace. Diakses tanggal 2019-04-10.

britannica.com

"Novartis AG | Swiss company". Encyclopedia Britannica (dalam bahasa Inggris). Diakses tanggal 2020-01-21.
"Ciba-Geigy AG | Swiss pharmaceutical company". Encyclopedia Britannica (dalam bahasa Inggris). Diakses tanggal 2020-01-21.

efpia.eu

"The Pharmaceutical Industry in Figures - 2008 Edition". European Federation of Pharmaceutical Industries and Associations (EFPIA). hlm. 49. Diarsipkan dari versi asli (PDF) tanggal 16 September 2008. Diakses tanggal 25 August 2008.

fiercepharma.com

"Novartis slashing thousands more jobs in global reorganization, shifting many to India". FiercePharma.

gabionline.net

Staff, Generics and Biosimilars Initiative, 9 November 2012 Sandoz starts phase III US trial for biosimilar epoetin alfa Diarsipkan 20 October 2013 di Wayback Machine.

genengnews.com

Staff, EP Vantage. 25 April 2012
"Novartis Snags Remaining 23% Stake in Alcon with $12.9B Cash and Share Deal | GEN - Genetic Engineering and Biotechnology News". GEN - Genetic Engineering and Biotechnology News (dalam bahasa Inggris). 2010-12-15. Diakses tanggal 2020-01-14.

ifpma.org

IFPMA Member List Diarsipkan 7 February 2014 di Wayback Machine.

journalstar.com

Staff and wire reports for the Journal Star (LIncoln, Nebraska) 14 August 2013 Novartis reviews business; analyst urges selling OTC unit

macrotrends.net

"Novartis AG Revenue 2006-2018 | NVS". www.macrotrends.net. Diakses tanggal 2019-03-11.

novartis.com

"Novartis Annual Report 2019" (PDF).
"Share Ownership". Novartis (dalam bahasa Inggris). 2019-12-31. Diakses tanggal 2020-09-20.
"Novartis Annual Report 2012" (PDF). Novartis. Diarsipkan dari versi asli (PDF) tanggal 2013-02-28. Diakses tanggal 6 February 2018.

nytimes.com

Jr, Donald G. McNeil (2010-06-28). "The Drug Industry: GlaxoSmithKline, Merck and Novartis Again Rank Highest on Access to Poor". The New York Times (dalam bahasa Inggris). ISSN 0362-4331. Diakses tanggal 2020-01-21.

pharmaceutical-technology.com

"GSK Pharma completes acquisition of Novartis Healthcare's vaccines business" (dalam bahasa Inggris). Diakses tanggal 2020-01-21.

pharmaphorum.com

"A history of Novartis -". pharmaphorum.com (dalam bahasa Inggris). 2013-09-20. Diakses tanggal 2020-01-21.

phrma.org

PhRMA Member List Diarsipkan 6 October 2013 di Wayback Machine.

reuters.com

uk.reuters.com

Reuters, 21 October 2010 Biosimilars take off at Novartis generics unit Diarsipkan 20 October 2013 di Wayback Machine.

sciencemuseumgroup.org.uk

collection.sciencemuseumgroup.org.uk

"J R Geigy SA 1857 - 1970".
"J. R. Geigy Soc. An." Diarsipkan dari versi asli tanggal 2020-08-05.

seattletimes.com

"Novartis 1Q profit jumps 12 percent as heart drug sales soar". Business. The Seattle Times. Associated Press. 19 April 2018. Diakses tanggal 2018-04-20.

sec.gov

"SEC 2010".
"20-F". www.sec.gov. hlm. 63. Diakses tanggal 2019-03-11.

seqirus.com

"CSL completes Novartis influenza vaccine acquisition in Germany". www.seqirus.com. Diarsipkan dari versi asli tanggal 2018-12-19. Diakses tanggal 2019-01-09.

thehindubusinessline.com

Datta, P. T. Jyothi (2015-12-18). "Novartis consolidates global services operations at Hyderabad centre". The Hindu BusinessLine. Diakses tanggal 2020-02-06.

thepharmaletter.com

"Novartis to split Pharma business unit; names new CEOs". www.thepharmaletter.com. Diakses tanggal 2020-01-09.

web.archive.org

IFPMA Member List Diarsipkan 7 February 2014 di Wayback Machine.
PhRMA Member List Diarsipkan 6 October 2013 di Wayback Machine.
"Novartis Annual Report 2012" (PDF). Novartis. Diarsipkan dari versi asli (PDF) tanggal 2013-02-28. Diakses tanggal 6 February 2018.
Reuters, 21 October 2010 Biosimilars take off at Novartis generics unit Diarsipkan 20 October 2013 di Wayback Machine.
Staff, Generics and Biosimilars Initiative, 9 November 2012 Sandoz starts phase III US trial for biosimilar epoetin alfa Diarsipkan 20 October 2013 di Wayback Machine.
"CSL completes Novartis influenza vaccine acquisition in Germany". www.seqirus.com. Diarsipkan dari versi asli tanggal 2018-12-19. Diakses tanggal 2019-01-09.
"J. R. Geigy Soc. An." Diarsipkan dari versi asli tanggal 2020-08-05.

who.int

apps.who.int

Staff, WHO. Access to Medicine Index, 2012

worldcat.org

Morse, Andrew (2013-11-11). "Novartis Sells Unit for $1.68 Billion". Wall Street Journal (dalam bahasa Inggris). ISSN 0099-9660. Diakses tanggal 2020-01-21.
Jr, Donald G. McNeil (2010-06-28). "The Drug Industry: GlaxoSmithKline, Merck and Novartis Again Rank Highest on Access to Poor". The New York Times (dalam bahasa Inggris). ISSN 0362-4331. Diakses tanggal 2020-01-21.

wsj.com

Roland, Denise. "Novartis Pharmaceuticals Head to Depart Amid Restructuring". WSJ (dalam bahasa Inggris). Diakses tanggal 2020-01-09.
Morse, Andrew (2013-11-11). "Novartis Sells Unit for $1.68 Billion". Wall Street Journal (dalam bahasa Inggris). ISSN 0099-9660. Diakses tanggal 2020-01-21.

yahoo.com

finance.yahoo.com

"Glaxo (GSK) Buys Novartis' Stake in Consumer Healthcare JV". finance.yahoo.com. Diakses tanggal 2019-03-11.